Structure

InChI Key XNKLLVCARDGLGL-JGVFFNPUSA-N
Smiles Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O
InChI
InChI=1S/C10H12N2O4/c1-6-4-12(10(15)11-9(6)14)8-3-2-7(5-13)16-8/h2-4,7-8,13H,5H2,1H3,(H,11,14,15)/t7-,8+/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C10H12N2O4
Molecular Weight 224.22
AlogP -0.71
Hydrogen Bond Acceptor 5.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 2.0
Polar Surface Area 84.32
Molecular species NEUTRAL
Aromatic Rings 1.0
Heavy Atoms 16.0

Metabolites Network

visNetwork

Bioactivity

Mechanism of Action Action Reference
Human immunodeficiency virus type 1 reverse transcriptase inhibitor INHIBITOR FDA
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Hydrolase
50-500 60-9600 - - -
Secreted protein
- - 44000 - -
Assay Description Organism Bioactivity Reference
Ability to inhibit the replication of HIV-1 IIIB infected C8166 cells Homo sapiens 80.0 nM
Tested in vitro for the antiviral activity in CEM-SS cells infected with HIV-1 Homo sapiens 59.0 nM
Compound was evaluated for the inhibition of HIV replication using HIV-1 infected CEM cells. Homo sapiens 160.0 nM
Compound was evaluated for the inhibition of HIV replication using HIV-2 infected CEM cells. Homo sapiens 270.0 nM
Effective concentration of compound achieving 50% protection in CEM cell lines against the cytopathic effect of HIV-1 Homo sapiens 90.0 nM
Activity against HIV-1 in CEM cells (in vitro) Homo sapiens 800.0 nM
Activity against HIV-2 in CEM cells (in vitro) Homo sapiens 775.0 nM
Compound was tested for anti-HIV-1 activity in CEM/0 cell line Homo sapiens 250.0 nM
Concentration required to protect CEM/0 cells against the cytopathicity of HIV-1 by 50% Human immunodeficiency virus 1 651.0 nM
Concentration required to protect CEM/0 cells against the cytopathicity of HIV-2 by 50% Human immunodeficiency virus 770.0 nM
Effective concentration that causes 50 % inhibition of HIV-1 in CEM/0 cells, was determined. Homo sapiens 0.4 ug.mL-1
Effective concentration that causes 50 % inhibition of HIV-2 in CEM/0 cells, was determined. Homo sapiens 1.45 ug.mL-1
Antiviral activity was measured on HIV-1 in wild-type CEM/O cells Homo sapiens 180.0 nM Antiviral activity was measured on HIV-1 in wild-type CEM/O cells Homo sapiens 180.0 nM
Antiviral activity was measured on HIV-2 in wild-type CEM/O cells Homo sapiens 260.0 nM Antiviral activity was measured on HIV-2 in wild-type CEM/O cells Homo sapiens 260.0 nM
In vitro effective compound concentration required to protect CEM/O cells against the cytopathogenicity of HIV-1 Homo sapiens 651.0 nM
In vitro effective compound concentration required to protect CEM/O cells against the cytopathogenicity of HIV-2 Homo sapiens 770.0 nM
Effective concentration that causes 50 % inhibition of HIV-2 in CEM/TK- cells, was determined. Homo sapiens 45.0 ug.mL-1
In vitro inhibition of HIV-1 replication in human T-lymphocytic cells (CEM). Human immunodeficiency virus 1 180.0 nM
Antiviral activity evaluated as the ability to inhibit the replication of HIV-1 in human T-lymphocytic cells (CEM) Homo sapiens 180.0 nM
In vitro inhibition of HIV-2 replication in human T-lymphocytic cells (CEM). Human immunodeficiency virus 2 260.0 nM

Related Entries

Environmental Exposure

Countries
South Africa

Cross References

Resources Reference
ChEBI 63581
ChEMBL CHEMBL991
DrugBank DB00649
DrugCentral 2478
FDA SRS BO9LE4QFZF
Human Metabolome Database HMDB0014787
KEGG C07312
PharmGKB PA451494
PubChem 18283
SureChEMBL SCHEMBL38661
ZINC ZINC000000137884